PRESS RELEASE published on 04/04/2023 at 03:00, 1 year 7 months ago MedMira Reports Second Quarter Results FY2023
PRESS RELEASE published on 03/14/2023 at 21:31, 1 year 8 months ago Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
PRESS RELEASE published on 02/20/2023 at 23:00, 1 year 9 months ago MedMira Enters into Partnership with Maternova for USA and Latin America
PRESS RELEASE published on 01/11/2023 at 14:22, 1 year 10 months ago MedMira receives CE mark for its VYRA(TM) CoV2Flu Antigen Test
PRESS RELEASE published on 01/04/2023 at 00:59, 1 year 10 months ago Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira's RVF Technology(R)
Published on 11/22/2024 at 23:55, 10 hours 36 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 1 minute ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 26 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 1 minute ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 16 hours 16 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 16 hours 37 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 35 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 31 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
